ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 42977970

FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications.

Xia J and 3 others. Biomark Res, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications. Papers, record 42977970. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42977970

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
FGFBPs in health and tumors: emerging prognostic biomarkers and therapeutic implications.
Journal
Biomark Res
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-11-06

Source PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xia JJie
2Xiao YYang
3Li YYongsheng
4Zhao HHuakan

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Y2024003Chongqing University Cancer Hospital Research Capacity Enhancement ProjectPubMed
82273212National Natural Science Foundation of ChinaPubMed
CSTB2025NSCQ-GPX0702Chongqing Natural Science FoundationPubMed
KJQN202400110Science and Technology Research Program of Chongqing Education CommissionPubMed

Source PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References203

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,430,763Ionizing Radiation and Estrogen Affecting Growth Factor Genes in an Experimental Breast Cancer Model.Int J Mol Sci2022https://conductscience.org/library/papers/36430763PubMed
239,817,679Cancer statistics, 2025.CA Cancer J Clin2025https://conductscience.org/library/papers/39817679PubMed
311,077,050Differential regulation of a fibroblast growth factor-binding protein by receptor-selective analogs of retinoic acid.Biochem Pharmacol2000https://conductscience.org/library/papers/11077050PubMed
433,529,461BAP1 promotes viability and migration of ECA109 cells through KLF5/CyclinD1/FGF-BP1.FEBS Open Bio2021https://conductscience.org/library/papers/33529461PubMed
534,061,869Genomic relevance of FGF14 and associated genes on the prognosis of pancreatic cancer.PLoS One2021https://conductscience.org/library/papers/34061869PubMed
627,121,396Up-regulation of FGFBP1 signaling contributes to miR-146a-induced angiogenesis in human umbilical vein endothelial cells.Sci Rep2016https://conductscience.org/library/papers/27121396PubMed
734,741,226The Identification of Blood Biomarkers of Chronic Neuropathic Pain by Comparative Transcriptomics.Neuromolecular Med2022https://conductscience.org/library/papers/34741226PubMed
830,019,538A fine-needle aspiration-based protein signature discriminates benign from malignant breast lesions.Mol Oncol2018https://conductscience.org/library/papers/30019538PubMed
939,507,711Investigating the role of disulfidptosis related genes in radiotherapy resistance of lung adenocarcinoma.Front Med (Lausanne)2024https://conductscience.org/library/papers/39507711PubMed
1012,173,043Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo.Oncogene2002https://conductscience.org/library/papers/12173043PubMed

1 to 10 of 203

See all 203 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42977970

GET https://conductscience.org/api/papers/v1/42977970/references?page=2

API referenceFor AI assistants